| CB-1158 |
CB-1158 |
2095732-06-0 |
| Tirzepatide |
新型双重GIP\GLP-1 |
2023788-19-2 |
| APS-2-79 |
APS-2-79 盐酸盐 |
2002381-31-7 |
| GNE140 |
(R)-GNE-140 |
2003234-63-5 |
| L-685 458 |
CS-2367 |
292632-98-5 |
| Kw-2871 |
Kw-2871 |
292819-64-8 |
| SCRIPTAID |
SCRIPTAID |
287383-59-9 |
| A 286982 |
A 286982 |
280749-17-9 |
| Elexacaftor |
ELEXACAFTOR |
2216712-66-0 |
| WNK463 |
N-(叔丁基)-1-(1-(5-(5-(三氟甲基)-1,3,4-恶二唑-2-基)吡啶-2-基)哌啶-4-基)-1H-咪唑-5-甲酰胺 |
2012607-27-9 |
| CID 2745687 |
CID 2745687 |
264233-05-8 |
| NSC-703786 |
4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯胺 |
260443-89-8 |
| N-Boc-1,2,5,6-tetrahydropyridine-4-boronic acid pinacol ester |
N-Boc-1,2,5,6-四氢吡啶-4-硼酸频哪醇酯 |
286961-14-6 |
| UK-371804 |
化合物UK371804 |
256477-09-5 |
| xav-939 |
3,5,7,8-四氢-2-[4-(三氟甲基)苯基]-4H-噻喃并[4,3-D]嘧啶-4-酮 |
284028-89-3 |
| Sparsentan (RE-021) |
4'-[(2-丁基-4-氧代-1,3-二氮杂螺[4.4]壬-1-烯-3-基)甲基]-N-(4,5-二甲基-3-异恶唑基)-2'-(乙氧基甲基)-[1,1'-联苯]-2-磺酰胺 |
254740-64-2 |
| Benzenepropanoic acid, a-[4-(9-bromo-2,3-dimethylnaphtho[2,3-b]thien-4-yl)-2,6-dimethylphenoxy]-,(aR)- |
ERTIPROTAFIB |
251303-04-5 |
| reslizumab |
RESLIZUMAB |
241473-69-8 |
| ALE-0540
(ALE0540) |
ALE-0540 |
234779-34-1 |
| N-[3-Chloro-4-(3-fluorobenzyloxy)phenyl]-6-iodoquinazolin-4-amine |
N-[3-氯-4-(3-氟苄氧基)苯基]-6-碘喹唑啉-4-胺 |
231278-20-9 |
QQ
微信
